Torrent Pharmaceuticals Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Chaitanya Auti
- Category: Market
CMP Rs 4,634.90 (9 Oct 2026). 52W range Rs 3,480.60 to Rs 5,250.00. PE 82.48. 2027 base Rs 5,140, bull Rs 5,246.
Quick Answer
The Torrent Pharmaceuticals share price forecast for 2027 centres on a conservative case of Rs 5,034, a base case of Rs 5,140 and a bull case of Rs 5,246, against a current price of Rs 4,634.90. These targets scale today’s price by reported EPS growth at a constant PE multiple, so they rest on earnings the company has already delivered, not on broker forecasts. The base case implies 10.9% upside from today’s price. The daily technical setup reads bearish.
Torrent Pharmaceuticals share price prediction 2027 comes down to earnings growth and the multiple investors pay for it, and the reported numbers give a measured answer. The stock trades at Rs 4,634.90 on NSE as of 9 October 2026, 11.7% below its 52-week high of Rs 5,250.00, after the company reported net profit of Rs 2,138.18 crore for FY26.
This Torrent Pharmaceuticals stock forecast 2027 builds conservative, base and bull scenarios from exchange-reported financials, shareholding data and daily price indicators, with every assumption shown.
Click Here – Get Free Investment Predictions
Torrent Pharmaceuticals Share Price Today and Key Data
The Torrent Pharmaceuticals share price today is Rs 4,634.90 on NSE, up 0.39% on the day. The market capitalisation stands at Rs 1,77,822 crore. Over the past year the price has risen 30.5% from Rs 3,550.50. Every Torrent Pharmaceuticals stock forecast figure below starts from this price.
| Metric | Value |
|---|---|
| Company | Torrent Pharmaceuticals (TORNTPHARM) |
| Current Price | Rs 4,634.90 |
| 52-Week High | Rs 5,250.00 (3 August 2026) |
| 52-Week Low | Rs 3,480.60 (14 October 2025) |
| Market Cap | Rs 1,77,822 crore |
| PE Ratio | 82.48 |
| Industry PE | 37.59 |
| PB Ratio | 21.15 |
| EPS (TTM) | Rs 56.68 |
| Return on Equity | 25.49% |
| Debt to Equity | 1.79 |
| Dividend Yield | 0.72% |
| Book Value per Share | Rs 221.09 |
What Is the Torrent Pharmaceuticals Share Price Prediction for 2027?
The Torrent Pharmaceuticals share price prediction for 2027 is a conservative case of Rs 5,034, a base case of Rs 5,140 and a bull case of Rs 5,246. Against Rs 4,634.90, these imply 8.6% upside, 10.9% upside and 13.2% upside. They are model scenarios built from reported EPS growth, not broker targets.
| Scenario | EPS Growth Basis | EPS Estimate | PE Multiple | Implied Value | Upside vs Current Price |
|---|---|---|---|---|---|
| Conservative Case | Lower of FY26 growth (13.2%) and 4-year CAGR (8.6%) | Rs 61.56 (+8.6%) | Unchanged from today (price to EPS ratio kept constant) | Rs 5,034 | +8.6% |
| Base Case | Average of the two | Rs 62.86 (+10.9%) | Unchanged from today (price to EPS ratio kept constant) | Rs 5,140 | +10.9% |
| Bull Case | Higher of the two | Rs 64.16 (+13.2%) | Unchanged from today (price to EPS ratio kept constant) | Rs 5,246 | +13.2% |
Each target takes today’s price of Rs 4,634.90 and scales it by the EPS growth assumed for that case, which is the same as holding the PE multiple constant. The conservative case uses the lower of the FY26 EPS growth and the 4-year EPS CAGR, the base case uses their average and the bull case uses the higher figure. Together they form the Torrent Pharmaceuticals target price range for the FY27 outlook over the next 12 months, and the range is not a point estimate.
Torrent Pharmaceuticals Share Price Forecast: What Has to Go Right by 2027
Each Torrent Pharmaceuticals target price below depends on a specific EPS outcome, and the text states that outcome next to the number.
Conservative Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,034
Reaching Rs 5,034 needs EPS to rise 8.6% to Rs 61.56 while the stock keeps its current PE multiple. That follows the slower 4-year EPS CAGR of 8.6%.
Base Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,140
Reaching Rs 5,140 needs EPS to rise 10.9% to Rs 62.86, the average of the FY26 growth rate and the 4-year CAGR. Net profit growth of 3.3% in Q1 FY27 is below that pace, so earnings need to speed up to reach this level.
Bull Case for the Torrent Pharmaceuticals Share Price Target: Rs 5,246
Reaching Rs 5,246 needs EPS to rise 13.2% to Rs 64.16 with the PE multiple held at today’s level. That sits inside the 52-week range of Rs 3,480.60 to Rs 5,250.00. A daily close above the nearest resistance level of Rs 4,909.63 (50-day SMA) would be the first technical confirmation.
Torrent Pharmaceuticals Financial Performance: Revenue, Profit and Margins
Torrent Pharmaceuticals earned net profit of Rs 2,138.18 crore on revenue of Rs 13,886.15 crore in FY26, with profit up 11.9% and revenue up 20.3% compared with FY25. Diluted EPS was Rs 63.92 against Rs 56.47 a year earlier, and that earnings base anchors the Torrent Pharmaceuticals share price forecast.
| Year | Revenue (Rs Cr) | Net Profit (Rs Cr) | EPS (Rs) | Operating Margin | Net Margin |
|---|---|---|---|---|---|
| FY22 | 8,704.60 | 777.18 | 45.93 | 30.77% | 8.93% |
| FY23 | 9,665.29 | 1,245.23 | 36.79 | 30.01% | 12.88% |
| FY24 | 10,785.75 | 1,656.38 | 48.94 | 32.76% | 15.36% |
| FY25 | 11,539.36 | 1,911.25 | 56.47 | 32.30% | 16.56% |
| FY26 | 13,886.15 | 2,138.18 | 63.92 | 22.70% | 15.40% |
In the latest reported quarter, Q1 FY27 (quarter ended June 2026), revenue was Rs 4,909 crore against Rs 3,141 crore a year earlier (+56.3%), and the bottom line was a net profit of Rs 566 crore against a net profit of Rs 548 crore (+3.3%). Operating margin was 33.73% versus 31.81% in the year-ago quarter. Cash flow from operations was Rs 3,022.71 crore in FY26 against Rs 2,585.11 crore in FY25. Together these figures set the earnings base for the Torrent Pharmaceuticals share price prediction.
Check the Univest Screener for live Torrent Pharmaceuticals fundamentals
Is Torrent Pharmaceuticals Overvalued or Undervalued Right Now?
Torrent Pharmaceuticals trades at a PE of 82.48 against an industry PE of 37.59, which places the stock at a 119.4% premium to the industry average. The price-to-book ratio is 21.15 on a book value of Rs 221.09 per share. Return on equity of 25.49% means the company earns Rs 25.49 of profit for every Rs 100 of shareholder equity.
Debt to equity is 1.79, so borrowings equal about 179% of shareholder equity. The company declared a dividend of Rs 38.00 per share for FY26, a yield of 0.72% at the current price. This valuation context frames the Torrent Pharmaceuticals stock price prediction for 2027 without relying on any outside forecast.
Torrent Pharmaceuticals Stock Analysis: Technical Outlook
Torrent Pharmaceuticals stock trades below its 50-day SMA of Rs 4,909.63 and above its 200-day EMA of Rs 4,493.11, and the combined daily indicators read bearish. The 52-week high of Rs 5,250.00 was set on 3 August 2026, while the 52-week low of Rs 3,480.60 came on 14 October 2025.
| Indicator | Reading | Signal |
|---|---|---|
| RSI (14) | 36.92 | Weak momentum |
| MACD (12,26,9) | -64.89 vs signal -35.81 | Bearish |
| ADX (14) | 28.85 | Established trend |
| Supertrend (10,3) | Price below Rs 4,950.15 | Bearish |
| 50-day SMA | Rs 4,909.63 | Price below |
| 200-day EMA | Rs 4,493.11 | Price above |
The nearest support level sits at Rs 4,493.11 (200-day EMA) and Rs 3,480.60 (52-week low). The nearest resistance level sits at Rs 4,909.63 (50-day SMA) and Rs 4,950.15 (Supertrend). A sustained move above the nearest resistance would support the Torrent Pharmaceuticals share price prediction 2027 base case, and this Torrent Pharmaceuticals stock analysis uses daily candles only. Chart signals add context to the Torrent Pharmaceuticals share price target without changing the earnings maths.
Torrent Pharmaceuticals Shareholding Pattern
Promoters hold 60.78% of Torrent Pharmaceuticals as of Jul 2026, down from 68.31% in Sep 2025 across the last 5 quarters. FII holding is 17.97% (up from 15.92% in Sep 2025) and DII holding is 12.87% (up from 9.28% in Sep 2025), which puts combined institutional holding at 30.84%. Public shareholders own 8.38%. Shareholding data is one input for any Torrent Pharmaceuticals stock forecast.
Key Risks to the Torrent Pharmaceuticals Share Price Target for 2027
Earnings and Margin Risk
Operating margin has ranged from 22.70% to 32.76% between FY22 and FY26, so a slip toward the lower end would trim the EPS estimate behind the Torrent Pharmaceuticals stock forecast. Revenue was up 20.3% in FY26, and slower revenue growth would weigh on the profit path.
Valuation Risk
The PE of 82.48 is 119.4% above the industry PE of 37.59. Every target here holds the multiple constant, so a narrowing of that premium would leave returns below these targets even if earnings grow as assumed.
Size and Liquidity Risk
Market capitalisation stands at Rs 1,77,822 crore. Investors should check daily traded volumes and order book depth on NSE before sizing a position, because price moves can be sharper when volumes thin out. Liquidity is a practical constraint on any Torrent Pharmaceuticals stock price target.
Balance Sheet Risk
Debt to equity of 1.79 means borrowings stand at about 179% of shareholder equity. A rise in borrowing costs or a jump in debt would weigh on profit and on the multiple behind the Torrent Pharmaceuticals share price forecast.
Technical Risk
The daily indicators read bearish, so the targets above may need a technical turn before the price follows earnings. A daily close below Rs 4,493.11 (200-day EMA) would weaken the setup further.
Conclusion
This Torrent Pharmaceuticals stock analysis puts the share price target range for 2027 at Rs 5,034 to Rs 5,246, with a base case of Rs 5,140 against Rs 4,634.90 today. The inputs are a PE of 82.48 that sits at a 119.4% premium to the industry average, EPS growth of 13.2% in FY26 and a daily technical setup that reads bearish. The next quarterly result will show which scenario is gaining ground. This analysis is educational, so consult a SEBI-registered advisor before acting on it.
Download the Univest iOS App or Univest Android App to track Torrent Pharmaceuticals live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Torrent Pharmaceuticals Share Price Prediction 2027
What is the Torrent Pharmaceuticals share price target for 2027?
Ans. The Torrent Pharmaceuticals share price forecast for 2027 has a conservative case of Rs 5,034, a base case of Rs 5,140 and a bull case of Rs 5,246. These are model scenarios based on reported EPS growth, and they are not guaranteed outcomes.
What is the Torrent Pharmaceuticals share price today?
Ans. Torrent Pharmaceuticals trades at Rs 4,634.90 on NSE as of 9 October 2026, up 0.39% on the day. The 52-week range is Rs 3,480.60 to Rs 5,250.00.
Is Torrent Pharmaceuticals a good stock to buy for 2027?
Ans. The data points in different directions: the PE of 82.48 is at a 119.4% premium to the industry average, EPS grew 13.2% in FY26 and the daily technical setup reads bearish. This article does not constitute investment advice, so consult a SEBI-registered advisor before deciding.
Can Torrent Pharmaceuticals stock reach Rs 5,246 in 2027?
Ans. Reaching Rs 5,246 needs EPS to rise 13.2% from Rs 56.68 with the PE multiple held at today’s level, plus a daily close above Rs 4,909.63 (50-day SMA). This is a scenario, not a guarantee.
What are the support and resistance levels for Torrent Pharmaceuticals?
Ans. The nearest support levels are Rs 4,493.11 (200-day EMA) and Rs 3,480.60 (52-week low), and the nearest resistance levels are Rs 4,909.63 (50-day SMA) and Rs 4,950.15 (Supertrend).
What are the main risks for Torrent Pharmaceuticals stock in 2027?
Ans. The main risks to the Torrent Pharmaceuticals share price forecast are a fall in operating margin from the 22.70% to 32.76% range seen since FY22, slower revenue growth after FY26 revenue was up 20.3%, and thin trading volumes. Debt to equity of 1.79 adds balance sheet sensitivity.
How is the Torrent Pharmaceuticals target price for 2027 calculated?
Ans. Each target scales the current price by assumed EPS growth at a constant PE multiple. The conservative case uses 8.6% growth, the base case 10.9% and the bull case 13.2%, all drawn from the company’s reported FY26 and 4-year EPS growth.